Lumida
/ANIP
⌘K
ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

ANIP
$79.20USD-3.32%-2.72 today

MARKET CAP

1.8B

P/E (TTM)

9.6x

FWD P/E

8.0x

DAY RANGE

$79 – $82

52W RANGE

$63
$100

AI Summary

Stalk
Sell NowMedium

ANIP is in Stage 3 distribution with a confirmed bearish medium-term bias and unfavorable short-term conditions; price trades below declining EMAs in an oversold context, suggesting selling now into any short-lived relief rallies approaching intermediate resistance.

  • Q1 2026 revenue $237.5M (+20% YoY); 2026 guidance $1.08–1.14B
  • Cortrophin Gel revenue up 42% to $75.1M, addressing 285K-patient market
  • Medicare Part D access hurdles limit revenue from retina therapies
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRIC
TREND